Cost effectiveness of carbamazepine in refractory bipolar illness.
D001714:Bipolar Disorder / Q000188:drug therapy* / Q000191:economics / Q000523:psychology; D002220:Carbamazepine / Q000627:therapeutic use*; D004565:Electroconvulsive Therapy / Q000191:economics; D006760:Hospitalization / Q000191:economics; D006801:Humans; D008297:Male; D008875:Middle Aged
D002220:Carbamazepine